Armistice Capital, LLC Vertex Pharmaceuticals Inc Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

A detailed history of Armistice Capital, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 46,129 shares of VRTX stock, worth $18.4 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
46,129
Previous 36,059 27.93%
Holding current value
$18.4 Million
Previous $16.9 Million 26.93%
% of portfolio
0.36%
Previous 0.22%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$460.0 - $505.78 $4.63 Million - $5.09 Million
10,070 Added 27.93%
46,129 $21.5 Million
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $6.25 Million - $7.73 Million
-15,921 Reduced 30.63%
36,059 $16.9 Million
Q1 2024

May 15, 2024
SELL
$407.69 - $446.08 $18.8 Million - $20.5 Million
-46,020 Reduced 46.96%
51,980 $21.7 Million
Q4 2023

Feb 13, 2024
SELL
$343.0 - $410.68 $6.21 Million - $7.44 Million
-18,117 Reduced 15.6%
98,000 $39.9 Million
Q3 2023

Nov 14, 2023
SELL
$338.18 - $362.46 $2.67 Million - $2.86 Million
-7,883 Reduced 6.36%
116,117 $40.4 Million
Q2 2023

Aug 14, 2023
SELL
$314.42 - $351.91 $30.2 Million - $33.8 Million
-96,000 Reduced 43.64%
124,000 $43.6 Million
Q1 2023

May 15, 2023
BUY
$283.23 - $323.1 $20.4 Million - $23.3 Million
72,000 Added 48.65%
220,000 $69.3 Million
Q4 2022

Feb 14, 2023
SELL
$285.76 - $321.48 $571,520 - $642,960
-2,000 Reduced 1.33%
148,000 $42.7 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $44.4 Million - $49.5 Million
-162,000 Reduced 51.92%
150,000 $43.4 Million
Q2 2022

Aug 15, 2022
BUY
$234.96 - $292.55 $17.9 Million - $22.2 Million
76,000 Added 32.2%
312,000 $87.9 Million
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $55.8 Million - $65.8 Million
-252,000 Reduced 51.64%
236,000 $61.6 Million
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $26.2 Million - $33.1 Million
-148,000 Reduced 23.27%
488,000 $107 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $6.53 Million - $7.31 Million
36,000 Added 6.0%
636,000 $115 Million
Q2 2021

Aug 16, 2021
BUY
$187.49 - $221.1 $39 Million - $46 Million
208,000 Added 53.06%
600,000 $121 Million
Q1 2021

May 17, 2021
BUY
$207.02 - $241.31 $81.2 Million - $94.6 Million
392,000 New
392,000 $84.2 Million
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $13 Million - $16.1 Million
-65,000 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$166.71 - $223.91 $5.83 Million - $7.84 Million
35,000 Added 116.67%
65,000 $14.2 Million
Q3 2019

Nov 14, 2019
BUY
$166.23 - $187.09 $4.99 Million - $5.61 Million
30,000 New
30,000 $5.08 Million

Others Institutions Holding VRTX

# of Institutions
1,725
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $103B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email